Clostridioides Difficile Infection
📧 Sign up to get email alerts when something new happens for Clostridioides Difficile Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection
A non-interventional pilot study investigating the role of gut microbiota in Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-20Clinical Trial Update: Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients [EARLY_Phase 1]
A clinical trial evaluating oral vancomycin, probiotics, and placebo to prevent Clostridioides difficile infection in colonized patients has…
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections [NA]
The clinical trial evaluating Bacillus velezensis DSM 33864 to reduce recurrence of Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-17Clinical Trial Update: Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)
A clinical trial evaluating fidaxomicin for Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-01-27Clinical Trial Update: Prospective Trial of Oral Vancomycin Therapy vs. Placebo for Prevention of CDI [Phase 4]
Phase 4 trial investigating oral vancomycin vs placebo to prevent Clostridioides difficile infection has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-07-19Clinical Trial Update: Use of Bismuth Subsalicylate in Clostridium Difficile Colitis [Phase 4]
A Phase 4 trial evaluating Bismuth Subsalicylate for Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-27Clinical Trial Update: EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant [NA]
The NCT02968511 trial EGESTA evaluating emergent GI therapy for severe, complicated Clostridioides difficile infection using fecal microbiot…
-
CLINICAL_TRIALS withdrawal · 2017-05-10Clinical Trial Update: Addition of Lactobacillus to Metronidazole in Treatment of CDAD [Phase 4]
A Phase 4 trial evaluating addition of a Lactobacillus probiotic to metronidazole for Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-14Clinical Trial Update: Extended Treatment With Vancomycin for Clostridium Difficile Colitis [NA]
The clinical trial NCT00861887 evaluating extended vancomycin treatment for Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-27Clinical Trial Update: UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients
A non-interventional observational trial (NCT01622595) evaluating infectious complications in cancer patients sponsored by the University of…
-
CLINICAL_TRIALS withdrawal · 2014-12-08Clinical Trial Update: Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin [Phase 2, Phase 3]
A Phase 2/3 trial comparing oral vancomycin followed by fecal microbiota transplantation versus tapering oral vancomycin was terminated.
-
CLINICAL_TRIALS withdrawal · 2014-11-18Clinical Trial Update: Probiotics in Hospitalized Patients Study [NA]
A clinical trial evaluating probiotics for antibiotic-associated diarrhea and Clostridioides difficile infection in hospitalized patients wa…
-
CLINICAL_TRIALS withdrawal · 2014-05-28Clinical Trial Update: Fidaxomicin to Prevent Clostridium Difficile Colonization [Phase 4]
Phase 4 trial of fidaxomicin to prevent Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-12-13Clinical Trial Update: Treatment of C. Difficile Infection With Fecal Microbiota Transplantation (FMT) [NA]
A clinical trial investigating fecal microbiota transplantation for Clostridioides difficile infection has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-11-11Clinical Trial Update: Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections [Phase 2]
Phase 2 trial evaluating the safety and clinical effectiveness of the oral probiotic MIYA-BM to prevent recurrent Clostridioides difficile i…
-
CLINICAL_TRIALS withdrawal · 2012-08-28Clinical Trial Update: Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies [Phase 2, Phase 3]
This clinical trial assessing an oral colostrum-derived anti-Clostridioides difficile antibodies for Clostridioides difficile infection has …